Suppr超能文献

不合理处方及其在新生儿表面活性剂治疗中的费用:2018 年伊朗的公立和私立医院。

Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018.

机构信息

Department of Health Care Management, School of Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Neonatal Health Department, Population, Family and School Health Office, Deputy of Health, Ministry of Health and Medical Education, Tehran, Iran.

出版信息

BMC Pediatr. 2023 May 20;23(1):251. doi: 10.1186/s12887-023-04045-7.

Abstract

BACKGROUND

Irrational prescription and its subsequent costs are a major challenge worldwide. Health systems must provide appropriate conditions for the implementation of national and international strategies to prevent irrational prescription. The aim of the present study was to determine the irrational surfactant prescription among neonates with respiratory distress and the resulting direct medical costs for private and public hospitals in Iran.

METHODS

This was a cross-sectional descriptive study performed retrospectively using data belonged to 846 patients. Initially, the data were extracted from the patients' medical records and the information system of the Ministry of Health. The obtained data were then compared with the surfactant prescription guideline. Afterward, each neonatal surfactant prescription was evaluated based on the three filters listed in the guideline (including right drug, right dose, and right time). Finally, chi-square and ANOVA tests were used to investigate the inter-variable relationships.

RESULTS

The results showed that 37.47% of the prescriptions were irrational and the average costs of each irrational prescription was calculated as 274.37 dollars. It was estimated that irrational prescriptions account for about 53% of the total surfactant prescription cost. Among the selected provinces, Tehran and Ahvaz had the worst and the best performance, respectively. As well, public hospitals outperformed private hospitals in terms of the in drug selection, but they underperformed them in terms of the right dose determination.

CONCLUSION

The results of the present study are considered as a warning to insurance organizations, in order to reduce unnecessary costs caused by these irrational prescriptions by developing new service purchase protocols. Our suggestion is the use of educational interventions to reduce irrational prescriptions due to drug selection as well as using computer alert approaches to reduce irrational prescriptions caused by wrong dose administration.

摘要

背景

不合理处方及其后续费用是全球范围内的一个主要挑战。卫生系统必须为实施国家和国际战略提供适当的条件,以防止不合理处方。本研究旨在确定伊朗私立和公立医院患有呼吸窘迫的新生儿中不合理表面活性剂处方的情况,以及由此产生的直接医疗费用。

方法

这是一项回顾性的横断面描述性研究,使用了 846 名患者的数据。最初,数据从患者的病历和卫生部的信息系统中提取。然后,将获得的数据与表面活性剂处方指南进行比较。此后,根据指南中列出的三个过滤器(包括正确的药物、正确的剂量和正确的时间)评估每个新生儿表面活性剂的处方。最后,使用卡方检验和 ANOVA 检验来研究变量之间的关系。

结果

结果显示,37.47%的处方不合理,每个不合理处方的平均费用为 274.37 美元。估计不合理处方占总表面活性剂处方费用的 53%左右。在所选择的省份中,德黑兰和阿瓦兹的表现最差和最好,分别。此外,公立医院在药物选择方面优于私立医院,但在确定正确剂量方面则不如私立医院。

结论

本研究的结果被认为是对保险公司的一个警告,以便通过制定新的服务购买协议来减少这些不合理处方造成的不必要费用。我们的建议是使用教育干预措施来减少由于药物选择而导致的不合理处方,以及使用计算机警报方法来减少由于错误剂量给药而导致的不合理处方。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b5/10199481/a0772a50a0db/12887_2023_4045_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验